Tertiary sulphonamide derivatives as dual acting small molecules that inhibit LSD1 and suppress tubulin polymerisation against liver cancer

被引：17

作者：

Ding, Lijuan ^{[1
]}

Wei, Feng ^{[1
]}

Wang, Nanya ^{[1
]}

Sun, Yue ^{[1
]}

Wang, Qiang ^{[1
]}

Fan, Xia ^{[1
]}

Qi, Ling ^{[2
]}

Wang, Shudong ^{[1
]}

机构：

[1] First Hosp Jilin Univ, Changchun, Peoples R China

[2] Guangzhou Med Univ, Qingyuan Peoples Hosp, Affiliated Hosp 6, Qingyuan, Peoples R China

来源：

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2021年 / 36卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Tertiary sulphonamide; liver cancer; Bel-7402; cells; tubulin polymerisation; LSD1; DEMETHYLASE; 1; LSD1; INVASION; GROWTH; CELLS;

D O I：

10.1080/14756366.2021.1917564

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of tertiary sulphonamide derivatives were synthesised and evaluated for their antiproliferative activity against liver cancer cell lines (SNU-475, HepG-2, and Bel-7402). Among these tertiary sulphonamides, compound 17a displayed the best anti-liver cancer activity against Bel-7402 cells with an IC50 value of 0.32 mu M. Compound 17a could effectively inhibit tubulin polymerisation with an IC50 value of 1.27 mu M. Meanwhile, it selectively suppressed LSD1 with an IC50 value of 63 nM. It also concentration-dependently inhibited migration against Bel-7402 cells. Importantly, tertiary sulphonamide 17a exhibited the potent antitumor activity in vivo. All these findings revealed that compound 17a might be a tertiary sulphonamide-based dual inhibitor of tubulin polymerisation and LSD1 to treat liver cancer.

引用

页码：1563 / 1572

页数：10

共 22 条

[1] Challenges in liver cancer and possible treatment approaches [J].

Anwanwan, David ;

Singh, Santosh Kumar ;

Singh, Shriti ;

Saikam, Varma ;

Singh, Rajesh .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1873 (01)

[2] Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A) [J].

Borrello, Maria Teresa ;

Schinor, Benjamin ;

Bartels, Katharina ;

Benelkebir, Hanae ;

Pereira, Sara ;

Al-Jamal, Wafa T. ;

Douglas, Leon ;

Duriez, Patrick J. ;

Packham, Graham ;

Haufe, Guenter ;

Ganesan, A. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (10) :2099-2101

[3] Liver cancer: Approaching a personalized care [J].

Bruix, Jordi ;

Han, Kwang-Hyub ;

Gores, Gregory ;

Llovet, Josep Maria ;

Mazzaferro, Vincenzo .

JOURNAL OF HEPATOLOGY, 2015, 62 :S144-S156

[4]

Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411

[5] Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5(4H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site [J].

El-Naggar, Abeer M. ;

Eissa, Ibrahim H. ;

Belal, Amany ;

El-Sayed, Amira A. .

RSC ADVANCES, 2020, 10 (05) :2791-2811

[6] Basil polysaccharide attenuates hepatocellular carcinoma metastasis in rat by suppressing H3K9me2 histone methylation under hepatic artery ligation-induced hypoxia [J].

Feng, Bing ;

Zhu, Ying ;

Su, Zuqing ;

Tang, Lipeng ;

Sun, Chaoyue ;

Li, Caiyun ;

Zheng, Guangjuan .

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 107 :2171-2179

[7] Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors [J].

Gehling, Victor S. ;

Mcgrath, John P. ;

Duplessis, Martin ;

Khanna, Avinash ;

Brucelle, Francois ;

Vaswani, Rishi G. ;

Cote, Alexandre ;

Stuckey, Jacob ;

Watson, Venita ;

Cummings, Richard T. ;

Balasubramanian, Srividya ;

Iyer, Priya ;

Sawant, Priyanka ;

Good, Andrew C. ;

Albrecht, Brian K. ;

Harmange, Jean-Christophe ;

Audia, James E. ;

Bellon, Steven F. ;

Trojer, Patrick ;

Levell, Julian R. .

ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (06) :1213-1220

[8] Biological roles of LSD1 beyond its demethylase activity [J].

Gu, Feiying ;

Lin, Yuxin ;

Wang, Zhun ;

Wu, Xiaoxin ;

Ye, Zhenyue ;

Wang, Yuezhen ;

Lan, Huiyin .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2020, 77 (17) :3341-3350

[9] Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation [J].

Hagras, Mohamed ;

El Deeb, Moshira A. ;

Elzahabi, Heba S. A. ;

Elkaeed, Eslam B. ;

Mehany, Ahmed B. M. ;

Eissa, Ibrahim H. .

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) :640-658

[10] 4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors [J].

He, Xingrui ;

Gao, Yuan ;

Hui, Zi ;

Shen, Guodong ;

Wang, Shuo ;

Xie, Tian ;

Ye, Xiang-Yang .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (10)

← 1 2 3 →